Cardiology Perspective

 
 

  • Monkeypox: What Do Experts Actually Think?   How much do we really know about the emerging risk of monkeypox? Join experts as they discuss the current situation, what people should focus on, and what to expect going forward.
  • This Is Your Brain on COVID-19   Do we know how COVID attacks the brain, producing symptoms such as distorted sense of smell? F. Perry Wilson comments on the data we have so far.
  • The Medical Student Teaching Medicine About Structural Racism   Robert A. Harrington interviews LaShyra Nolen, a medical student and the 2021 recipient of the American Medical Student Association's Racial Justice in Medicine Award.
  • Infographic: Best & Worst Places to Practice 2022 The five best and worst states for physicians to practice medicine are evaluated based on 12 criteria such as compensation, burnout, and malpractice payment amounts, among others.
  • This Nurse Wants Change, Not a Pizza Party, for Nurses Month Pizza parties and discounts are all very well, but given that Nurses Month is also Mental Health Awareness Month, this nurse would like to see that issue addressed.
  • What Will It Take to Cure EHR Note Bloat? Stop typing the equivalent of War and Peace and embrace click parsimony are among the tips from Epic's CMO and others for cutting the time spent on electronic health records.
  • Tirzepatide: 'Exciting' and Promising in Lowering A1c   Tirzepatide is the newest player in the quest for lowering A1c in people with type 2 diabetes. Dr Anne Peters describes the novel agent -- what it can do for patients now and in the future.
  • May 20 2022 This Week in Cardiology   Ischemia vs anatomic testing for CAD, UK-TAVI trial, TAVI for AR? and post-PCI anti-thrombotics are the topics John Mandrola, MD, discusses in this week’s podcast.
  • Best & Worst Places to Practice 2022 Some states offer lots of perks and temptations for physician practices, although each doctor has their own priorities that make some places more desirable.
  • Management of Post-COVID Cardiac Symptoms   How primary care physicians can evaluate and counsel patients with persistent cardiovascular symptoms after COVID.
  • How Medicine Is Failing a Nation in Pain   Pain is central to every specialty, and we all played a part in the opioid crisis, says Dr Haider Warraich, author of The Song of Our Scars: The Untold Story of Pain.
  • At What Point Does Comfort Care Become Murder?   Drs Robert Glatter, Ferdinando Mirarchi, Lewis Nelson, and Thaddeus Pope discuss a recent legal case and how it may affect end-of-life care moving forward.
  • Episode 4: Better Ways to Sustain Weight Loss in Type 2 Diabetes   Patients with type 2 diabetes and obesity have more options today than ever before. Join host Dr Silvio Inzucchi and obesity expert Dr Ania Jastreboff as they discuss ways to support weight loss.
  • Smoking Cessation Drug Side Effects Aren't as Bad as You Think There are many reasons why patients don't get smoking cessation counseling, but fear of drug side effects shouldn't be one, writes Chris Labos, MD.
  • May 13 2022 This Week in Cardiology   Obstructive hypertrophic cardiomyopathy and mavacamten, SGLT2 inhibitors, the triple whammy, espresso, and clinician burnout are the topics John Mandrola, MD, covers in today’s podcast.
  • Medscape Cardiologist Compensation Report 2022 Medscape's Cardiologist Compensation Report 2022 explores income sources, pay gaps, and attitudes about work as COVID's impact on medical practices declines.
  • The Case for Post-COVID Steroids   Dr F. Perry Wilson cautions against changing practice on the basis of a single study.
  • Are You Eligible for a New Therapy That Might Prevent COVID-19? Learn More On Evusheld   WebMD's Chief Medical Officer, John Whyte, MD, discusses the new FDA-authorized preventative drug for COVID-19 called Evusheld.
  • ACC 2022 Making Healthy (Plant-Based) Diets the Easy Choice   Drs Michelle O'Donoghue and Robert Ostfeld discuss plant-based nutrition and how to make it easier for us to choose healthy foods to improve our cardiovascular health.
  • Five New Neurology Studies: Possible Breakthroughs, Some Failures   Dr Christoph Diener on promising early results in muscular dystrophy and Creutzfeldt-Jakob disease, and discouraging ones for aducanumab.